Contact
searchSearch
HMP Global

Traumatic Brain Injury Excellence Forum

Traumatic Brain Injury
Excellence Forum
Leaders in the field sharing authoritative insights and institutional best practices.

Sports Concussion Research: What’s in the Pipeline?
Videos
Sports Concussion Research: What’s in the Pipeline?
11/20/2020
In this video, Christina L. Master, MD, reviews areas of research that have grown significantly over the past year, including earlier interventions with active management and characterizing concussion profiles, and how they may impact...
In this video, Christina L. Master, MD, reviews areas of research that have grown significantly over the past year, including earlier interventions with active management and characterizing concussion profiles, and how they may impact...
In this video, Christina L....
11/20/2020
Neurology
Advances in Diagnostic and Treatment Research in Sports Concussion
Videos
Advances in Diagnostic and Treatment Research in Sports Concussion
11/02/2020
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L. Master, MD, details the increasing interest in characterizing concussion subtypes to help target interventions, the ongoing search for the “holy grail” diagnostic test for concussion, and more. She recently...
In this video, Christina L....
11/02/2020
Neurology
Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
Videos
Bridging Knowledge Gaps in Sports Concussion Prevention and Treatment: Evidence for Rule Changes and More
10/23/2020
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L. Master, MD, reviews evidence of the role of rule changes in preventing concussion in hockey and football, research on active rehabilitation in the treatment of concussion, and more. She recently discussed these...
In this video, Christina L....
10/23/2020
Neurology
John Leddy, MD, on Returning to Exercise After Concussion
Podcasts
John Leddy, MD, on Returning to Exercise After Concussion
09/08/2020
He discusses important considerations for returning to exercise post-concussion, explains common pitfalls in the diagnosis and treatment of sports-related concussion, and addresses treating acute sports-related concussion via early testing...
He discusses important considerations for returning to exercise post-concussion, explains common pitfalls in the diagnosis and treatment of sports-related concussion, and addresses treating acute sports-related concussion via early testing...
He discusses important...
09/08/2020
Neurology
Important Research Advances in the Clinical Science of Concussion
Videos
Important Research Advances in the Clinical Science of Concussion
09/05/2020
In this video, Christina L. Master, MD, discusses recently published research on disparities in sports concussion when it comes to availability of flag football vs tackle football, the impact of active specialized sports medicine care vs a...
In this video, Christina L. Master, MD, discusses recently published research on disparities in sports concussion when it comes to availability of flag football vs tackle football, the impact of active specialized sports medicine care vs a...
In this video, Christina L....
09/05/2020
Neurology
5 Questions About the Long-Term Impact of Severe TBI Among Older Adults
Q&As
5 Questions About the Long-Term Impact of Severe TBI Among Older Adults
03/25/2020
More adults aged 65 years or older are experiencing severe traumatic brain injury (TBI), and results of a new study show that these patients’ risk of mortality and severe morbidity is high. Lead study author Matthew J. Maiden, PhD, answered...
More adults aged 65 years or older are experiencing severe traumatic brain injury (TBI), and results of a new study show that these patients’ risk of mortality and severe morbidity is high. Lead study author Matthew J. Maiden, PhD, answered...
More adults aged 65 years or...
03/25/2020
Neurology
Julian Bailes, MD, on Everything You Need to Know About TBI
Podcasts
Julian Bailes, MD, on Everything You Need to Know About TBI
03/05/2020
In this podcast, Julian Bailes, MD, from NorthShore University HealthSystem, discusses traumatic brain injury, including mild traumatic brain injury and chronic traumatic encephalopathy.
In this podcast, Julian Bailes, MD, from NorthShore University HealthSystem, discusses traumatic brain injury, including mild traumatic brain injury and chronic traumatic encephalopathy.
In this podcast, Julian Bailes,...
03/05/2020
Neurology
5 Questions About the Challenges of Diagnosing mTBI in Youth
Q&As
5 Questions About the Challenges of Diagnosing mTBI in Youth
03/03/2020
Traumatic brain injury affects people of all ages, but children are at high risk especially if they participate in sports. Nicole D. Reams, MD, a sports neurologist at NorthShore University HealthSystem, answers our questions about the...
Traumatic brain injury affects people of all ages, but children are at high risk especially if they participate in sports. Nicole D. Reams, MD, a sports neurologist at NorthShore University HealthSystem, answers our questions about the...
Traumatic brain injury affects...
03/03/2020
Neurology
Q&As
5 Questions About Returning to Play After a Sports-Related Concussion
10/19/2019
John Leddy, MD, from the University at Buffalo, answers our questions about returning to play after a sports-related concussion, a topic he also spoke about at the American Academy of Neurology’s Sports Concussion Conference.
John Leddy, MD, from the University at Buffalo, answers our questions about returning to play after a sports-related concussion, a topic he also spoke about at the American Academy of Neurology’s Sports Concussion Conference.
John Leddy, MD, from the...
10/19/2019
Neurology
Q&As
4 Questions About Molecular, Cellular, and Circuit Mechanisms of Cognitive Enhancement
09/16/2019
Alcino Silva, PhD, answers our questions about molecular memory systems and how they relate to neurological diseases—a topic that he will also discuss at the American Neurological Association’s Annual Meeting.
Alcino Silva, PhD, answers our questions about molecular memory systems and how they relate to neurological diseases—a topic that he will also discuss at the American Neurological Association’s Annual Meeting.
Alcino Silva, PhD, answers our...
09/16/2019
Neurology

News

Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
News
Semaglutide May Lower Risk of Alzheimer Disease in Patients With Type 2 Diabetes
11/05/2024
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes and obesity prescribed semaglutide had a 40% to 70% lower risk of a first-time Alzheimer disease (AD) diagnosis compared with patients taking other antidiabetic medications, according to a study published in...
Patients with type 2 diabetes...
11/05/2024
Psych Congress Network
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
News
Alone or Together, CBT and Modafinil Improve MS-Related Fatigue
11/01/2024
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug modafinil, CBT, and a combination of both were associated with comparable, significant improvement in fatigue at 12 weeks in patients with MS and problematic fatigue.
The wake-promoting drug...
11/01/2024
Neurology
Gene therapy
News
Concerns Linger After Gene Therapy Shows Long-Term Benefit for Cerebral Adrenoleukodystrophy
10/28/2024
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel (eli-cel) gene therapy for cerebral adrenoleukodystrophy (CALD) helped patients maintain neurological function, but also my have caused hematologic malignancies in some patients.
Elivaldogene autotemcel...
10/28/2024
Neurology
Patient with family
News
During Recovery, Stroke Patients Benefit from Supportive Social Networks
10/24/2024
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and friends are beneficial for blood pressure improvement among patients who experienced a stroke, according to a study published online in the International Journal of Cerebrovascular Disease and Stroke. “In aging...
Large networks of family and...
10/24/2024
Neurology
International Stroke Burden Saw Hike Over Last 30 Years
News
International Stroke Burden Saw Hike Over Last 30 Years
10/22/2024
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has increased from 1990 to 2021, according to recent findings from a global burden of disease (GBD) study published in The Lancet Neurology.
International stroke burden has...
10/22/2024
Neurology
Hands holding a head in profile with an illustrated heart over brain
News
Antiseizure Meds May Increase Cardiovascular Risk in Older Adults With Epilepsy
10/21/2024
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy is associated with new-onset cardiovascular events in older adults, according to study results published in JAMA Neurology.
A lifetime history of epilepsy...
10/21/2024
Neurology
FDA approval stamp
News
FDA Approves Infusion Treatment for Advanced Parkinson Disease in Adults
10/18/2024
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa and foslevodopa), the first 24-hour continuous subcutaneous infusion of levodopa-based therapy for managing motor fluctuations in adults with advanced Parkinson disease (PD), approved by the FDA.
AbbVie’s VYALEV (foscarbidopa...
10/18/2024
Neurology
Investigational Drug Improves Motor Function in Patients With SMA
News
Investigational Drug Improves Motor Function in Patients With SMA
10/16/2024
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational muscle-targeted therapy, improved motor function in patients with spinal muscular atrophy (SMA), late-stage biopharmaceutical company Scholar Rock recently announced.
Apitegromab, an investigational...
10/16/2024
Neurology
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
News
Tolebrutinib Delays Disability Progression in Nonrelapsing Secondary Progressive MS
10/15/2024
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to onset of 6-month confirmed disability progression compared with placebo in patients with nonrelapsing secondary progressive MS, according to results presented at the European Committee for Treatment and...
Tolebrutinib delayed the time to...
10/15/2024
Neurology
An orange prescription container with generic pills spilling out in front of it
News
Masked Taper Plus CBT for Insomnia Effective in Benzodiazepine Discontinuation
10/10/2024
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined with cognitive behavioral therapy for insomnia (CBTI) were associated with improved benzodiazepine receptor agonist discontinuation in patients receiving treatment for insomnia
A masked drug taper combined...
10/10/2024
Psych Congress Network

Alzheimer's Disease CME Series

Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources To view accreditation information/faculty disclosures for the program, click 
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesOnline Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient Resources
11/19/2020
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease: Caregiver Connections, Shared Decision Making, and Patient ResourcesTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click...
Early Alzheimer’s Disease:...
11/19/2020
Neurology
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer Disease: Efficacy and Safety Data To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data Online Form - PBHLN-NLN Alzheimers Video Series
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety Data
11/17/2020
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early Alzheimer’s Disease: Efficacy and Safety DataTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation...
Emerging Treatments for Early...
11/17/2020
Neurology
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action To view accreditation information/faculty disclosures for the program, click 
Emerging Treatments for Early...
11/12/2020
Neurology
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology
11/12/2020
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease Overview: Burden of Disease, Quality-of-Life Impacts, and Pathophysiology Online Form - PBHLN-NLN Alzheimers Video Series
Early Alzheimer’s Disease...
11/12/2020
Neurology
Claim-Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of Action
11/12/2020
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early Alzheimer’s Disease: Mechanisms of ActionTo claim credit for the program, click HERE for the evaluation. You will need to log in or create an account with NACCME, and then click on the evaluation button...
Emerging Treatments for Early...
11/12/2020
Neurology
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease
11/10/2020
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations and Clinical Needs in Early Alzheimer’s Disease To view accreditation information/faculty disclosures for the program, click 
Current Treatment Limitations...
11/10/2020
Neurology

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use